搜索筛选:
搜索耗时3.1343秒,为你在为你在102,285,761篇论文里面共找到 9 篇相符的论文内容
发布年度:
[期刊论文] 作者：Xiao-Li Wei,De-Shen Wang,Shao-,
来源：世界胃肠病学杂志：英文版（电子版） 年份：2014
AIM:To explore the association between AT-rich interactive domain 1A(ARID1A)protein loss by immunohistochemistry and both clinicopathologic characteristics and...
Icotinib antagonizes ABCG2-mediated multidrug resistance, but not the pemetrexed resistance mediated
[会议论文] 作者：Zhe-Sheng Chen,De-Shen Wang,Dong-Hua Yang,Rui-Hua Xu,
来源：2014医学科学前沿暨第三届个体化治疗与抗肿瘤药物研究新趋向研讨会 年份：2014
ABCG2 is a potential biomarker causing multidrug resistance (MDR) in Non-Small Cell Lung Cancer (NSCLC).We conducted this study to investigate whether Icoti...
[会议论文] 作者：Zhe-Sheng Chen,De-Shen Wang,Hui Zhang,Amit Tiwari,Atish Patel,Zhi Shi,
来源：2014第七届世界癌症大会 年份：2014
We found that tyrosine kinase inhibitors (TKIs) such as erlotinib, lapatinib, nilotinib, sunitinib, tandutinib, and icotinib could reverse ATP-binding cassette (ABC) transporter-mediated multidrug res...
[会议论文] 作者：Dong-dong Yang,Zhan-Hong Chen,De-Shen Wang,Yu Hong-En,Jia-Huan Lu,Rui-Hua Xu,Zhao-Lei Zeng,
来源：2019中国肿瘤学大会 年份：2019
...
[期刊论文] 作者：Xiao-Li Wei,De-Shen Wang,Shao-Yan Xi,Wen-Jing Wu,Dong-Liang Chen,Zhao-Lei Zeng,Rui-Yu Wang,Ya-Xin Huang,
来源：World Journal of Gastroenterology 年份：2014
AIM:To explore the association between AT-rich interactive domain 1A(ARID1A)protein loss by immunohistochemistry and both clinicopathologic characteristics and...
[期刊论文] 作者：De-Shen Wang,Ming-Tao Hu,Zhi-Qiang Wang,Chao Ren,Miao-Zhen Qiu,Hui-Yan Luo,Ying Jin,William Pat Fong,,
来源：癌症 年份：2022
背景与目的 预防化疗所致恶心呕吐在肿瘤治疗的全程管理中是十分重要的一环.本研究评价了在高危女性胃肠道肿瘤患者中,在帕洛诺司琼、地塞米松基础上联用阿瑞匹坦能否进一步预防或减轻FOLFIRI方案(氟尿嘧啶、亚叶酸和伊立替康)或FOLFOX方案(氟尿嘧啶、亚叶酸和......
[期刊论文] 作者：Yu,Ming-Ming He,Kai-Yan Liu,Hui-Yan Luo,Dong-Sheng Zhang,Yin Jin,Feng-Hua Wang,Zhi-Qiang Wang,De-Shen Wang,
来源：Chinese Journal of Cancer 年份：2015
Introduction: Right-sided colon cancer(RSCC) and left-sided colorectal cancer(LSCRC) differ with respect to their biology and genomic patterns. This study aimed...
Comparison of bevacizumab with cetuximab as the first? line bio? chemotherapy for patients with meta
[会议论文] 作者：Feng Wang,De-shen Wang,Zhao-lei Zeng,Rui-hua Xu,Zhe-zhen Li,Yun-xin Lu,Zhi-qiang Wang,Long Bai,Dong-liang,
来源：第四届广州国际肿瘤学会议 年份：2015
The present observational cohort study was designed to elucidate the efficacy and safety profile of bevacizumab or cetuximab in the first-line treatment of...
Comparison of bevacizumab with cetuximab as the first? line bio? chemotherapy for patients with meta
[会议论文] 作者：Feng Wang,Long Bai,Zhe-zhen Li,Chao Ren,Dong-sheng Zhang,Qi Zhao,De-shen Wang,Dong-liang Chen,Yun-xin,
来源：第四届广州国际肿瘤学会议 年份：2015
The present observational cohort study was designed to elucidate the efficacy and safety profile of bevacizumab or cetuximab in the first-line treatment of metastatic colorectal cancer(mCRC)in Chinese...
相关搜索：
